Tag: Omics Lab Services Market Analysis

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Omics Lab Services Market Expansion Outlook: What Revenue Opportunities Lie Ahead?

The omics laboratory services market experienced considerable expansion, projecting an increase from $109.47 billion in 2025 to $126.6 billion in 2026, driven by a compound annual growth rate of 15.7%. This historical uptick is largely due to several key factors: the broadening scope of life sciences research, the burgeoning pharmaceutical R&D pipelines, the greater accessibility of omics technologies, a trend towards outsourcing laboratory operations, and the amplification of collaborative efforts in both academic and clinical research settings.

The realm of omics laboratory services is poised for substantial expansion in the upcoming years, with projections indicating a surge to $224.14 billion by 2030, driven by a compound annual growth rate of 15.4%. This burgeoning expansion over the projected timeframe is largely fueled by the escalating embrace of personalized medicine research, augmented investments in the field of systems biology, the proliferation of artificial intelligence-powered bioinformatics instruments, a heightened need for comprehensive omics solutions, and a significant emphasis on drug discovery methodologies that are informed by data. Key developments anticipated during this forecast period encompass a greater call for unified multi-omics analysis, increased utilization of contract research outsourcing, the broadening application of bioinformatics for data interpretation, a more widespread adoption of high-throughput analytical technologies, and an intensified commitment to supporting translational research endeavors.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

Omics Lab Services Market Expansion Supported By Key Demand Factors

The increasing incidence of genetic disorders is anticipated to be a key driver for the expansion of the omics lab services market. These genetic disorders stem from alterations or errors within a person’s DNA, which can either be passed down through generations or arise independently. The growing occurrence of these conditions is partly attributable to innovations in diagnostic methodologies, especially next-generation sequencing and other advanced genomic technologies, which have greatly enhanced the capacity to pinpoint and confirm a broad spectrum of genetic conditions that were once either overlooked or incorrectly identified. Omics lab services play a crucial role in addressing genetic diseases by meticulously examining intricate biological information to detect specific mutations and molecular alterations, thereby facilitating prompt diagnosis and tailored therapeutic approaches. As an illustration, by October 2024, data from the Cystic Fibrosis Trust, a charitable organization in the UK focused on assisting individuals affected by cystic fibrosis, indicated that the number of registered cystic fibrosis patients rose from 11,148 in 2022 to 11,318 in 2023, signifying a year-over-year increment of 1.5% in patient registrations. Consequently, the escalating prevalence of genetic diseases is directly contributing to the market’s upward trajectory in omics lab services.

Omics Lab Services Market Segmentation And Category Breakdown

The omics lab services market covered in this report is segmented –

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions

3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications

5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization

2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics

3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics

4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting

5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

Omics Lab Services Market Growth Trends Influencing Competitive Dynamics

Leading entities within the omics laboratory services sector are actively engaged in creating novel offerings, including high-throughput genomics, with the objective of expediting both biomedical investigations and personalized medical approaches. High-throughput genomics involves the deployment of cutting-edge technologies designed for the swift sequencing and examination of substantial quantities of genetic material, thereby facilitating efficient, large-scale genetic inquiries. As an illustration, in September of 2024, the Translational Genomics Research Institute (TGen), a non-profit medical research organization situated in the United States, unveiled the Center for Spatial Multi-Omics (COSMO). This facility delivers whole-transcriptome information at a high resolution through the utilization of sequencing-based Visium HD, integrated with histological staining techniques, and additionally provides tissue preparation services like Tissue Microarray (TMA) creation for economical, multi-sample analyses. The adaptable systems offered, augmented by cell segmentation driven by machine learning, facilitate the detailed visualization and charting of molecular information within intact tissue samples, thereby fostering progress in personalized medicine and the study of diseases.

Omics Lab Services Market Competitive Analysis Of Major Industry Participants

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Access The Complete Omics Lab Services Market Report:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Omics Lab Services Market Geographic Distribution And Regional Opportunities

North Americawas the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Omics Lab Services Market Change Between 2026 And 2030?

The omics lab services market size has experienced rapid growth in recent years. It is anticipated to expand from $109.47 billion in 2025 to $126.6 billion in 2026, at a compound annual growth rate (CAGR) of 15.7%. The observed growth in the historic period stems from the expansion of life sciences research activities, growth of pharmaceutical r&d pipelines, increasing availability of omics technologies, rising outsourcing of laboratory services, and the expansion of academic and clinical research collaborations.

The omics lab services market is anticipated to undergo significant expansion in the coming years. Its size is projected to reach $224.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. This expansion during the forecast period can be linked to the increased adoption of personalized medicine research, rising investments in systems biology, the broadening availability of AI-enabled bioinformatics tools, a growing need for complete omics solutions, and an intensified focus on data-driven drug discovery. Prominent trends for the forecast period encompass a rising demand for integrated multi-omics analysis, an increased uptake of contract research services, the expansion of bioinformatics-driven data interpretation, greater utilization of high-throughput analytical platforms, and an enhanced emphasis on supporting translational research.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

Which Strategic Drivers Are Supporting The Omics Lab Services Market Development?

The increasing occurrence of genetic illnesses is projected to fuel the expansion of the omics lab services market in the future. These diseases are conditions resulting from anomalies or alterations in an individual’s DNA, which may be inherited or arise without a known cause. The frequency of genetic diseases is increasing because improvements in diagnostic methods, especially next-generation sequencing and other genomic instruments, have greatly enhanced the capacity to discover and pinpoint numerous genetic conditions that were formerly undetected or incorrectly categorized. Omics lab services assist with genetic diseases through the examination of intricate biological data to pinpoint mutations and molecular shifts, thus facilitating early detection and tailored therapeutic approaches. As an illustration, in October 2024, the Cystic Fibrosis Trust, a UK-based charitable organization focused on aiding individuals with cystic fibrosis, reported that 11,148 cystic fibrosis patients were registered in 2022, a figure that climbed to 11,318 in 2023, signifying a 1.5% year-over-year rise in patient registrations. Consequently, the growing incidence of genetic disorders is propelling the expansion of the omics lab services market.

Which Segment-Based Categories Are Covered In The Omics Lab Services Market?

The omics lab services market covered in this report is segmented –

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions

3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications

5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization

2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics

3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics

4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting

5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

What Trends Are Driving Changes In The Omics Lab Services Market?

Leading companies in the omeprazole market are developing liquid ready-to-use formulations to boost patient convenience and compliance, especially benefiting individuals who struggle to swallow tablets or capsules. These liquid omeprazole formulations contribute to improved patient adherence, enhanced ease of use, precise dosage delivery, a quicker start of action, and greater medication stability. For example, in February 2024, Alkaloid AD, a pharmaceutical manufacturing firm based in North Macedonia, introduced liquid Omeprazole. This is the first ready-to-use liquid Omeprazole designed for patients with reflux esophagitis and GERD who cannot take tablets, and it incorporates a dual-chamber package. This innovation presents a more practical and accessible treatment choice for patients facing difficulties in swallowing tablets or capsules, such as young children, adults with dysphagia, those with gastric feeding tubes, or geriatric patients. The company has secured the initial international patent for a value-added medicine (VAM) for this product and has been granted marketing authorizations for both the Macedonian and UK markets.

Which Companies Are Engaged In The Omics Lab Services Market Environment?

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Access The Complete Omics Lab Services Market Report:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Which Region Contributes The Most To The Omics Lab Services Market?

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Omics Lab Services Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=28284&type=smp

Browse Through More Reports Similar to the Global Omics Lab Services Market 2026, By The Business Research Company

Olanzapine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

Proton Pump Inhibitors Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report

Clopidogrel Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clopidogrel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Omics Lab Services Market In 2026 And 2030?

The omics lab services market has seen rapid expansion in its size over recent years. Projections indicate it will increase from $109.47 billion in 2025 to $126.6 billion in 2026, at a compound annual growth rate (CAGR) of 15.7%. The historical growth of this market is attributable to the expansion of life sciences research activities, growth of pharmaceutical r&d pipelines, increasing availability of omics technologies, rising outsourcing of laboratory services, and expansion of academic and clinical research collaborations.

The omics lab services market size is set to experience quick growth over the upcoming years. It is projected to expand to $224.14 billion by 2030, achieving a compound annual growth rate (CAGR) of 15.4%. This anticipated growth during the forecast period is fueled by the escalating adoption of personalized medicine research, increased investments in systems biology, the proliferation of AI-enabled bioinformatics tools, a rising demand for comprehensive omics solutions, and a heightened focus on data-driven drug discovery. Prominent trends throughout this period include an increasing need for integrated multi-omics analysis, the growing utilization of contract research services, the expansion of bioinformatics-driven data interpretation, the rising deployment of high-throughput analytical platforms, and an enhanced emphasis on supporting translational research.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

Which Factors Are Influencing The Growth Of The Omics Lab Services Market?

The growing incidence of genetic conditions is anticipated to drive the expansion of the omics lab services market in the future. Genetic diseases are disorders arising from anomalies or alterations in an individual’s DNA, which can be inherited or emerge spontaneously. The occurrence of genetic diseases is increasing as advancements in diagnostic technologies, especially next-generation sequencing and other genomic tools, have significantly improved the capability to detect and identify a broad spectrum of genetic disorders that were previously undiagnosed or misclassified. Omics lab services play a crucial role in genetic diseases by analyzing intricate biological data to identify mutations and molecular shifts, thereby enabling early detection and customized treatment. For instance, in October 2024, as per the Cystic Fibrosis Trust, a UK-based charity committed to assisting individuals with cystic fibrosis, 11,148 cystic fibrosis patients were registered in 2022, and this count rose to 11,318 in 2023, signifying a 1.5% increase in patient registrations year-over-year. Thus, the escalating prevalence of genetic diseases is fueling the growth of the omics lab services market.

What Are The Main Segments Within The Omics Lab Services Market Segment Structure?

The omics lab services market covered in this report is segmented –

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions

3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications

5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization

2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics

3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics

4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting

5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

Which Trends Are Influencing Demand In The Omics Lab Services Market?

Leading companies in the omics lab services market are concentrating on developing innovative solutions, such as high-throughput genomics, to accelerate biomedical research and precision medicine. High-throughput genomics involves the utilization of advanced technologies to rapidly sequence and analyze large volumes of DNA or RNA, making efficient large-scale genetic studies possible. For instance, in September 2024, The Translational Genomics Research Institute (TGen), a US-based nonprofit medical research institute, launched the Center for Spatial Multi-Omics (COSMO). This center offers high-resolution whole-transcriptome data using sequencing-based Visium HD, combined with histological staining, and provides tissue processing services like Tissue Microarray (TMA) construction for cost-effective, multiplexed sample analysis. Its customizable platforms, enhanced by machine learning-driven cell segmentation, enable detailed visualization and mapping of molecular data within intact tissues, supporting advancements in precision medicine and disease research.

Who Are The Companies Participating In The Omics Lab Services Market?

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Get The Full Omics Lab Services Market Report:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Which Region Has The Greatest Market Share In The Omics Lab Services Market?

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Omics Lab Services Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Browse Through More Reports Similar to the Global Omics Lab Services Market 2026, By The Business Research Company

Olanzapine Market Report 2026

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

Proton Pump Inhibitors Market Report

https://www.thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report

Clopidogrel Market Report

https://www.thebusinessresearchcompany.com/report/clopidogrel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Omics Lab Services Market By The End Of 2030?

The omics lab services market size has experienced rapid expansion in recent years. It is projected to increase from $109.47 billion in 2025 to $126.6 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.7%. The market’s historical growth can be attributed to the expansion of life sciences research activities, growth of pharmaceutical r&d pipelines, increasing availability of omics technologies, rising outsourcing of laboratory services, and expansion of academic and clinical research collaborations.

The omics lab services market is anticipated to experience swift expansion in the coming years. Its valuation is projected to reach $224.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. This projected growth during the forecast timeframe is attributable to factors such as the expanding embrace of personalized medicine research, heightened investments in systems biology, the proliferation of AI-enabled bioinformatics tools, an escalating need for comprehensive omics solutions, and a sharpened emphasis on drug discovery propelled by data. Key developments expected within this period encompass a surging demand for integrated multi-omics analysis, a rise in the utilization of contract research services, the broadened scope of bioinformatics-driven data interpretation, an increased deployment of high-throughput analytical platforms, and a strengthened commitment to supporting translational research.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Omics Lab Services Market?

An increase in genetic disease cases is anticipated to drive the expansion of the omics lab services market in the future. These conditions stem from DNA abnormalities or mutations, which can be passed down or emerge spontaneously. The growing number of genetic disease cases is attributed to significant improvements in diagnostic technologies, such as next-generation sequencing and other genomic instruments, which have enhanced the capacity to identify numerous genetic disorders that were previously undetected or incorrectly categorized. Omics lab services aid in managing genetic diseases by scrutinizing intricate biological data to pinpoint mutations and molecular alterations, facilitating prompt diagnosis and tailored therapeutic approaches. As an illustration, the Cystic Fibrosis Trust, a UK charity assisting those with cystic fibrosis, reported in October 2024 that 11,148 cystic fibrosis patients were registered in 2022, a figure that climbed to 11,318 in 2023, showing a 1.5% annual rise in patient registrations. Consequently, the increased occurrence of genetic diseases is fueling the expansion of the omics lab services market.

Which Segment Classifications Shape The Omics Lab Services Market?

The omics lab services market covered in this report is segmented –

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions

3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications

5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization

2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics

3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics

4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting

5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

What Industry Trends Are Redefining The Omics Lab Services Market?

Leading companies within the omics lab services market are prioritizing the development of innovative solutions, such as high-throughput genomics, to accelerate both biomedical research and precision medicine efforts. High-throughput genomics involves leveraging advanced technologies to rapidly sequence and analyze significant volumes of DNA or RNA, thereby enabling efficient large-scale genetic studies. For example, in September 2024, The Translational Genomics Research Institute (TGen), a US-based nonprofit medical research institute, introduced the Center for Spatial Multi-Omics (COSMO). This center offers high-resolution whole-transcriptome data by using sequencing-based Visium HD in conjunction with histological staining, and also provides tissue processing services like Tissue Microarray (TMA) construction for economical, multiplexed sample analysis. Its adaptable platforms, further enhanced by machine learning-driven cell segmentation, allow for detailed visualization and mapping of molecular data within intact tissues, supporting advancements in precision medicine and disease research.

Which Companies Are Expanding Their Footprint In The Omics Lab Services Market?

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Read the full omics lab services market report here:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Which Regions Are Projected To Dominate The Omics Lab Services Market In The Coming Years?

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Omics Lab Services Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28284&type=smp

Browse Through More Reports Similar to the Global Omics Lab Services Market 2026, By The Business Research Company

Olanzapine Global Market Report

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

Proton Pump Inhibitors Global Market Report

https://www.thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report

Clopidogrel Global Market Report

https://www.thebusinessresearchcompany.com/report/clopidogrel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Omics Lab Services Market By The End Of 2030?

The omics lab services market size has experienced rapid expansion in recent years. It is projected to increase from $109.47 billion in 2025 to $126.6 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.7%. The market’s historical growth can be attributed to the expansion of life sciences research activities, growth of pharmaceutical r&d pipelines, increasing availability of omics technologies, rising outsourcing of laboratory services, and expansion of academic and clinical research collaborations.

The omics lab services market is anticipated to experience swift expansion in the coming years. Its valuation is projected to reach $224.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. This projected growth during the forecast timeframe is attributable to factors such as the expanding embrace of personalized medicine research, heightened investments in systems biology, the proliferation of AI-enabled bioinformatics tools, an escalating need for comprehensive omics solutions, and a sharpened emphasis on drug discovery propelled by data. Key developments expected within this period encompass a surging demand for integrated multi-omics analysis, a rise in the utilization of contract research services, the broadened scope of bioinformatics-driven data interpretation, an increased deployment of high-throughput analytical platforms, and a strengthened commitment to supporting translational research.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Omics Lab Services Market?

An increase in genetic disease cases is anticipated to drive the expansion of the omics lab services market in the future. These conditions stem from DNA abnormalities or mutations, which can be passed down or emerge spontaneously. The growing number of genetic disease cases is attributed to significant improvements in diagnostic technologies, such as next-generation sequencing and other genomic instruments, which have enhanced the capacity to identify numerous genetic disorders that were previously undetected or incorrectly categorized. Omics lab services aid in managing genetic diseases by scrutinizing intricate biological data to pinpoint mutations and molecular alterations, facilitating prompt diagnosis and tailored therapeutic approaches. As an illustration, the Cystic Fibrosis Trust, a UK charity assisting those with cystic fibrosis, reported in October 2024 that 11,148 cystic fibrosis patients were registered in 2022, a figure that climbed to 11,318 in 2023, showing a 1.5% annual rise in patient registrations. Consequently, the increased occurrence of genetic diseases is fueling the expansion of the omics lab services market.

Which Segment Classifications Shape The Omics Lab Services Market?

The omics lab services market covered in this report is segmented –

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions

3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications

5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization

2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics

3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics

4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting

5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

What Industry Trends Are Redefining The Omics Lab Services Market?

Leading companies within the omics lab services market are prioritizing the development of innovative solutions, such as high-throughput genomics, to accelerate both biomedical research and precision medicine efforts. High-throughput genomics involves leveraging advanced technologies to rapidly sequence and analyze significant volumes of DNA or RNA, thereby enabling efficient large-scale genetic studies. For example, in September 2024, The Translational Genomics Research Institute (TGen), a US-based nonprofit medical research institute, introduced the Center for Spatial Multi-Omics (COSMO). This center offers high-resolution whole-transcriptome data by using sequencing-based Visium HD in conjunction with histological staining, and also provides tissue processing services like Tissue Microarray (TMA) construction for economical, multiplexed sample analysis. Its adaptable platforms, further enhanced by machine learning-driven cell segmentation, allow for detailed visualization and mapping of molecular data within intact tissues, supporting advancements in precision medicine and disease research.

Which Companies Are Expanding Their Footprint In The Omics Lab Services Market?

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Read the full omics lab services market report here:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Which Regions Are Projected To Dominate The Omics Lab Services Market In The Coming Years?

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Omics Lab Services Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28284&type=smp

Browse Through More Reports Similar to the Global Omics Lab Services Market 2026, By The Business Research Company

Olanzapine Global Market Report

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

Proton Pump Inhibitors Global Market Report

https://www.thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report

Clopidogrel Global Market Report

https://www.thebusinessresearchcompany.com/report/clopidogrel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Omics Lab Services Market By The End Of 2030?

The omics lab services market size has experienced rapid expansion in recent years. It is projected to increase from $109.47 billion in 2025 to $126.6 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.7%. The market’s historical growth can be attributed to the expansion of life sciences research activities, growth of pharmaceutical r&d pipelines, increasing availability of omics technologies, rising outsourcing of laboratory services, and expansion of academic and clinical research collaborations.

The omics lab services market is anticipated to experience swift expansion in the coming years. Its valuation is projected to reach $224.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. This projected growth during the forecast timeframe is attributable to factors such as the expanding embrace of personalized medicine research, heightened investments in systems biology, the proliferation of AI-enabled bioinformatics tools, an escalating need for comprehensive omics solutions, and a sharpened emphasis on drug discovery propelled by data. Key developments expected within this period encompass a surging demand for integrated multi-omics analysis, a rise in the utilization of contract research services, the broadened scope of bioinformatics-driven data interpretation, an increased deployment of high-throughput analytical platforms, and a strengthened commitment to supporting translational research.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Omics Lab Services Market?

An increase in genetic disease cases is anticipated to drive the expansion of the omics lab services market in the future. These conditions stem from DNA abnormalities or mutations, which can be passed down or emerge spontaneously. The growing number of genetic disease cases is attributed to significant improvements in diagnostic technologies, such as next-generation sequencing and other genomic instruments, which have enhanced the capacity to identify numerous genetic disorders that were previously undetected or incorrectly categorized. Omics lab services aid in managing genetic diseases by scrutinizing intricate biological data to pinpoint mutations and molecular alterations, facilitating prompt diagnosis and tailored therapeutic approaches. As an illustration, the Cystic Fibrosis Trust, a UK charity assisting those with cystic fibrosis, reported in October 2024 that 11,148 cystic fibrosis patients were registered in 2022, a figure that climbed to 11,318 in 2023, showing a 1.5% annual rise in patient registrations. Consequently, the increased occurrence of genetic diseases is fueling the expansion of the omics lab services market.

Which Segment Classifications Shape The Omics Lab Services Market?

The omics lab services market covered in this report is segmented –

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions

3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications

5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization

2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics

3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics

4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting

5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

What Industry Trends Are Redefining The Omics Lab Services Market?

Leading companies within the omics lab services market are prioritizing the development of innovative solutions, such as high-throughput genomics, to accelerate both biomedical research and precision medicine efforts. High-throughput genomics involves leveraging advanced technologies to rapidly sequence and analyze significant volumes of DNA or RNA, thereby enabling efficient large-scale genetic studies. For example, in September 2024, The Translational Genomics Research Institute (TGen), a US-based nonprofit medical research institute, introduced the Center for Spatial Multi-Omics (COSMO). This center offers high-resolution whole-transcriptome data by using sequencing-based Visium HD in conjunction with histological staining, and also provides tissue processing services like Tissue Microarray (TMA) construction for economical, multiplexed sample analysis. Its adaptable platforms, further enhanced by machine learning-driven cell segmentation, allow for detailed visualization and mapping of molecular data within intact tissues, supporting advancements in precision medicine and disease research.

Which Companies Are Expanding Their Footprint In The Omics Lab Services Market?

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Read the full omics lab services market report here:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Which Regions Are Projected To Dominate The Omics Lab Services Market In The Coming Years?

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Omics Lab Services Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28284&type=smp

Browse Through More Reports Similar to the Global Omics Lab Services Market 2026, By The Business Research Company

Olanzapine Global Market Report

https://www.thebusinessresearchcompany.com/report/olanzapine-global-market-report

Proton Pump Inhibitors Global Market Report

https://www.thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report

Clopidogrel Global Market Report

https://www.thebusinessresearchcompany.com/report/clopidogrel-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the omics lab services market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Omics Lab Services Market in 2026, and what figure is it projected to hit by 2030?

The omics lab services market has witnessed rapid expansion in recent years. Its size is expected to increase from $109.47 billion in 2025 to $126.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.7%. The historical growth of this market can be ascribed to several factors, including the expansion of life sciences research activities, the growth of pharmaceutical r&d pipelines, increasing availability of omics technologies, rising outsourcing of laboratory services, and the expansion of academic and clinical research collaborations.

The omics lab services market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $224.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.4%. This projected growth is driven by factors such as the increasing uptake of personalized medicine research, greater investments in systems biology, the proliferation of AI-enabled bioinformatics tools, a surging demand for comprehensive omics solutions, and a heightened emphasis on data-centric drug discovery. Key trends observed during this period encompass a rising need for integrated multi-omics analysis, the increasing utilization of contract research services, the broadened scope of bioinformatics-powered data interpretation, the escalating deployment of high-throughput analytical platforms, and an intensified commitment to supporting translational research.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28284&type=smp

Which Drivers Are Affecting Market Participation In The Omics Lab Services Market?

The increasing occurrence of genetic illnesses is projected to fuel the expansion of the omics lab services market moving ahead. Genetic diseases are conditions resulting from irregularities or changes in an individual’s DNA, which may be passed down genetically or manifest without prior inheritance. The incidence of genetic diseases is increasing because breakthroughs in diagnostic tools, especially next-generation sequencing and other genomic instruments, have substantially enhanced the capacity to discover and pinpoint numerous genetic disorders that were previously undetected or misidentified. Omics lab services assist in managing genetic diseases by analyzing intricate biological information to pinpoint mutations and molecular alterations, facilitating prompt diagnosis and tailored therapeutic approaches. As an illustration, figures from October 2024, provided by the Cystic Fibrosis Trust, a UK-based charity supporting cystic fibrosis patients, show that 11,148 cystic fibrosis patients were registered in 2022, a number that rose to 11,318 in 2023, indicating a 1.5% year-over-year increase in patient registrations. Consequently, the growing occurrence of genetic conditions is propelling the expansion of the omics lab services market.

What Segment Classifications Make Up The Omics Lab Services Market?

The omics lab services market covered in this report is segmented –

1) By Type Of Omics Services: Genomics, Transcriptomics, Proteomics, Metabolomics, Epigenomics

2) By Service Model: Contract Services, In-House Services, Consultative Services, Collaborative Research, Custom Solutions

3) By Technology Platform: Next-Generation Sequencing (NGS), Microarray Technology, Mass Spectrometry, Chromatography, Bioinformatics Tools

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Other Applications

5) By End Users: Research Institutions, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions, Clinical Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing, Single-Cell Genomics, Comparative Genomic Hybridization

2) By Transcriptomics: Messenger Ribonucleic Acid (RNA) Sequencing, Non-Coding Ribonucleic Acid (RNA) Sequencing, Expression Profiling, Ribonucleic Acid (RNA) Microarrays, Single-Cell Transcriptomics

3) By Proteomics: Protein Identification, Protein Quantification, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping, Structural Proteomics

4) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Lipidomics, Fluxomics, Metabolic Fingerprinting

5) By Epigenomics: Deoxyribonucleic Acid (DNA) Methylation Analysis, Histone Modification Profiling, Chromatin Accessibility Assays, Chromatin Immunoprecipitation Sequencing, Non-Coding Ribonucleic Acid (RNA) Epigenetic Regulation

Which Competitive Trends Are Impacting The Structure Of The Omics Lab Services Market?

Leading companies within the omics lab services market are directing their efforts toward developing innovative solutions, such as high-throughput genomics, to accelerate biomedical research and advance precision medicine. High-throughput genomics utilizes advanced technologies to quickly sequence and analyze significant amounts of DNA or RNA, allowing for efficient large-scale genetic studies. As an example, in September 2024, The Translational Genomics Research Institute (TGen), a US-based nonprofit medical research institute, inaugurated the Center for Spatial Multi-Omics (COSMO). This center delivers high-resolution whole-transcriptome data using sequencing-based Visium HD alongside histological staining, and offers tissue processing services such as Tissue Microarray (TMA) construction for cost-effective, multiplexed sample analysis. Its customizable platforms, augmented by machine learning-driven cell segmentation, enable detailed visualization and mapping of molecular data within intact tissues, thereby supporting progress in precision medicine and disease research.

Which Major Industry Participants Are Leading The Omics Lab Services Market Growth?

Major companies operating in the omics lab services market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Labs Ltd., Metabolon Inc., Zymo Research Corporation, CD Genomics, BaseClear B.V., Strand Life Sciences Pvt. Ltd., Sengenics Corporation Pte Ltd., Psomagen Inc., Biocrates Life Sciences AG, Creative Proteomics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/omics-lab-services-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Omics Lab Services Market?

North America was the largest region in the omics lab services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics lab services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Omics Lab Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28284&type=smp

Browse Through More Reports Similar to the Global Omics Lab Services Market 2026, By The Business Research Company

Lab Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-supplies-global-market-report

Medical And Diagnostic Laboratory Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

Medical And Diagnostic Laboratory Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model